RxDoctor Payments Data

Jodi Towne, NP

Adult Health · Watertown, NYNPI 1487607651

Payments from drug & device makers

$439in general payments, 2019–2025

Across 20 payments — averaging $21.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$102
  • GSK$97
  • Grifols USA, LLC$47
  • Regeneron Healthcare Solutions, Inc.$45
  • Fisher & Paykel Healthcare Inc$35
  • Inspire Medical Systems, Inc.$23
  • plus $89 from 5 others

What the payments were for

  • Food & beverage$439100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$439 in reported general payments places this provider in the 50th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$29,453
Medicare patients
427
Services billed
649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter124$98,224
Breo ElliptaFluticasone/Vilanterol163$85,848
Dupixent PenDupilumab11$42,053
Arnuity ElliptaFluticasone Furoate109$31,001
Incruse ElliptaUmeclidinium Bromide54$26,950
Spiriva RespimatTiotropium Bromide26$21,623
Breztri AerosphereBudesonide/Glycopyr/Formoterol29$19,307
SymbicortBudesonide/Formoterol Fumarate40$18,504
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$15,800
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate55$12,250
Advair HfaFluticasone Propion/Salmeterol25$11,026
Fluticasone-SalmeterolFluticasone Propion/Salmeterol80$10,050
Albuterol Sulfate HfaAlbuterol Sulfate348$8,893
Qvar RedihalerBeclomethasone Dipropionate24$8,744
DuleraMometasone/Formoterol14$7,959

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta, Incruse Ellipta, Anoro Ellipta$97$257,823474 claims
AstraZenecaBreztri Aerosphere, Symbicort$102$37,81169 claims
Boehringer IngelheimSpiriva Respimat, Combivent Respimat$23$27,76939 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,828 adult health providers in New York.

Other adult health in Watertown

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →